Zenas BioPharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-30.5M | $-30.5M | $17.0K | $3.5M |
| FY2024 | $-119.7M | $-119.8M | $131.0K | $10.8M |
| FY2025 | $-172.3M | $-172.4M | $18.0K | $26.3M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-30.5M | $-30.5M | $17.0K | $3.5M |
| FY2024 | $-119.7M | $-119.8M | $131.0K | $10.8M |
| FY2025 | $-172.3M | $-172.4M | $18.0K | $26.3M |